These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30483049)

  • 1. Human Calmodulin Mutations.
    Jensen HH; Brohus M; Nyegaard M; Overgaard MT
    Front Mol Neurosci; 2018; 11():396. PubMed ID: 30483049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome-Associated Calmodulin Missense Variant, E141G.
    Boczek NJ; Gomez-Hurtado N; Ye D; Calvert ML; Tester DJ; Kryshtal D; Hwang HS; Johnson CN; Chazin WJ; Loporcaro CG; Shah M; Papez AL; Lau YR; Kanter R; Knollmann BC; Ackerman MJ
    Circ Cardiovasc Genet; 2016 Apr; 9(2):136-146. PubMed ID: 26969752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin Mutations in Human Disease.
    Hussey JW; Limpitikul WB; Dick IE
    Channels (Austin); 2023 Dec; 17(1):2165278. PubMed ID: 36629534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel
    Kato K; Isbell HM; Fressart V; Denjoy I; Debbiche A; Itoh H; Poinsot J; George AL; Coulombe A; Shea MA; Guicheney P
    Circ Arrhythm Electrophysiol; 2022 Mar; 15(3):e010572. PubMed ID: 35225649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks.
    Gomez-Hurtado N; Boczek NJ; Kryshtal DO; Johnson CN; Sun J; Nitu FR; Cornea RL; Chazin WJ; Calvert ML; Tester DJ; Ackerman MJ; Knollmann BC
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmogenic calmodulin E105A mutation alters cardiac RyR2 regulation leading to cardiac dysfunction in zebrafish.
    Da'as SI; Thanassoulas A; Calver BL; Beck K; Salem R; Saleh A; Kontogianni I; Al-Maraghi A; Nasrallah GK; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
    Ann N Y Acad Sci; 2019 Jul; 1448(1):19-29. PubMed ID: 30937913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Mosaicism in Calmodulinopathy.
    Wren LM; Jiménez-Jáimez J; Al-Ghamdi S; Al-Aama JY; Bdeir A; Al-Hassnan ZN; Kuan JL; Foo RY; Potet F; Johnson CN; Aziz MC; Carvill GL; Kaski JP; Crotti L; Perin F; Monserrat L; Burridge PW; Schwartz PJ; Chazin WJ; Bhuiyan ZA; George AL
    Circ Genom Precis Med; 2019 Sep; 12(9):375-385. PubMed ID: 31454269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex and Gene Influence Arrhythmia Susceptibility in Murine Models of Calmodulinopathy.
    Wren LM; DeKeyser JM; Barefield DY; Hawkins NA; McNally EM; Kearney JA; Wasserstrom JA; George AL
    Circ Arrhythm Electrophysiol; 2023 Sep; 16(9):e010891. PubMed ID: 37589122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Construct Suppression and Replacement Gene Therapy for the Treatment of All
    Hamrick SK; Kim CSJ; Tester DJ; Gencarelli M; Tobert KE; Gluscevic M; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2024 Aug; 17(8):e012036. PubMed ID: 39069900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of calmodulin regulation of RyR2 in controlling heart rhythm, the progression of heart failure and the antiarrhythmic action of dantrolene.
    Walweel K; Oo YW; Laver DR
    Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):135-142. PubMed ID: 27626620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin mutations affecting Gly114 impair binding to the Na
    Brohus M; Busuioc AO; Wimmer R; Nyegaard M; Overgaard MT
    Front Pharmacol; 2023; 14():1210140. PubMed ID: 37663247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished inhibition and facilitated activation of RyR2-mediated Ca
    Søndergaard MT; Liu Y; Brohus M; Guo W; Nani A; Carvajal C; Fill M; Overgaard MT; Chen SRW
    FEBS J; 2019 Nov; 286(22):4554-4578. PubMed ID: 31230402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human disease-associated calmodulin mutations alter calcineurin function through multiple mechanisms.
    Williams RB; Alam Afsar MN; Tikunova S; Kou Y; Fang X; Somarathne RP; Gyawu RF; Knotts GM; Agee TA; Garcia SA; Losordo LD; Fitzkee NC; Kekenes-Huskey PM; Davis JP; Johnson CN
    Cell Calcium; 2023 Jul; 113():102752. PubMed ID: 37245392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.
    Limpitikul WB; Dick IE; Tester DJ; Boczek NJ; Limphong P; Yang W; Choi MH; Babich J; DiSilvestre D; Kanter RJ; Tomaselli GF; Ackerman MJ; Yue DT
    Circ Res; 2017 Jan; 120(1):39-48. PubMed ID: 27765793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two EF-hand motifs in ryanodine receptor calcium release channels contribute to isoform-specific regulation by calmodulin.
    Xu L; Gomez AC; Pasek DA; Meissner G; Yamaguchi N
    Cell Calcium; 2017 Sep; 66():62-70. PubMed ID: 28807150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
    Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
    Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.
    Xu X; Yano M; Uchinoumi H; Hino A; Suetomi T; Ono M; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ikemoto N; Matsuzaki M
    Biochem Biophys Res Commun; 2010 Apr; 394(3):660-6. PubMed ID: 20226167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of calmodulin inhibition of cardiac sarcoplasmic reticulum Ca2+ release channel (ryanodine receptor).
    Xu L; Meissner G
    Biophys J; 2004 Feb; 86(2):797-804. PubMed ID: 14747315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes.
    Fukuda M; Yamamoto T; Nishimura S; Kato T; Murakami W; Hino A; Ono M; Tateishi H; Oda T; Okuda S; Kobayashi S; Koseki N; Kyushiki H; Yano M
    Biochem Biophys Res Commun; 2014 May; 448(1):1-7. PubMed ID: 24755079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure.
    Kato T; Yamamoto T; Nakamura Y; Nanno T; Fukui G; Sufu Y; Hamada Y; Maeda T; Nishimura S; Ishiguchi H; Murakami W; Fukuda M; Xu X; Hino A; Ono M; Oda T; Okuda S; Kobayashi S; Koseki N; Kyushiki H; Yano M
    Heart Rhythm; 2017 Jan; 14(1):120-127. PubMed ID: 27771553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.